Form 4: Encompass Health Director Leslye G. Katz Receives Additional Restricted Stock Units Due to Dividend Payment
SEC Form 4 Filing
Director Leslye G. Katz received 76 additional restricted stock units (RSUs) from Encompass Health due to a dividend payment on common stock.
Summary
- Leslye G. Katz, a director at Encompass Health Corp, received 76 restricted stock units (RSUs) on April 15, 2025, as a result of a dividend payment.
- The dividend paid on Encompass Health's common stock was $0.17 per share.
- The closing price of Encompass Health's common stock on the dividend payment date was $102.30.
- Following the transaction, Ms. Katz beneficially owns 46,181 shares of Encompass Health common stock.
- The RSUs were credited to Ms. Katz's account according to outstanding restricted stock unit award agreements, which stipulate that additional RSUs are awarded in connection with common stock dividend payments.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to director compensation, indicating a stable and ongoing practice of aligning director interests with shareholder returns. It's a neutral to slightly positive signal.
Positives
- The receipt of RSUs indicates continued alignment of the director's interests with those of the shareholders through dividend payments.
Industry Context
This type of equity compensation is common in publicly traded companies to align the interests of directors and management with those of shareholders. Dividend payments and subsequent RSU awards are a standard practice.
Comparison to Industry Standards
- Equity compensation through restricted stock units (RSUs) is a common practice among publicly traded companies, including those in the healthcare sector like Universal Health Services (UHS) and HCA Healthcare (HCA).
- These companies often use RSUs as part of their compensation packages to align the interests of directors and executives with shareholder value.
- The specific terms of RSU awards, such as vesting schedules and dividend equivalents, can vary across companies, but the underlying principle of incentivizing long-term performance remains consistent.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders by aligning the director's interests with dividend payouts.
Key Dates
| Date | Description |
|---|---|
| 04/15/2025 | Date of the transaction (acquisition of RSUs) and dividend payment. |
| 04/16/2025 | Date of signature for the Form 4 filing. |
Keywords
Encompass Health, Director, Leslye G. Katz, Restricted Stock Units, RSUs, Dividend, Beneficial Ownership, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.